Heidelberg Pharma AG (ETR:HPHA)

Heidelberg Pharma AG Balance Sheet

Financials in millions EUR. Fiscal year is December - November.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	24.93	14.98	29.42	43.44	81.33	6.14
Cash & Short-Term Investments	24.93	14.98	29.42	43.44	81.33	6.14
Cash Growth	-25.03%	-49.10%	-32.27%	-46.59%	1224.27%	23.27%
Accounts Receivable	0.13	0.01	0.28	0.98	1.1	1.02
Other Receivables	2.02	1.95	5.51	1.35	0.35	0.43
Receivables	2.15	1.95	5.79	2.32	1.45	1.45
Inventory	10.41	10.61	11.82	10.49	4.59	0.75
Prepaid Expenses	0.35	0.79	0.54	-	-	-
Other Current Assets	-	-	0	0.38	0.51	0.68
Total Current Assets	37.83	28.33	47.57	56.63	87.88	9.01
Property, Plant & Equipment	0.2	0.91	3.49	3.85	3.72	3.67
Goodwill	6.11	6.11	6.11	6.11	6.11	6.11
Other Intangible Assets	2.69	2.72	2.75	2.79	2.84	2.9
Other Long-Term Assets	0.06	0.07	0.81	0.97	0.03	0.03
Total Assets	46.9	38.14	60.72	70.35	100.58	21.73

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Accounts Payable	4.47	7.16	5.55	7.88	5.75	2.96
Accrued Expenses	-	0.84	1.03	1.04	1.03	0.78
Short-Term Debt	-	-	-	5.65	15.79	10.47
Current Portion of Leases	-	0.1	0.12	0.11	0.09	0.09
Current Unearned Revenue	1.13	0.03	1.2	4.97	5.02	0.49
Other Current Liabilities	1.56	3.07	0.1	0.13	0.25	0.15
Total Current Liabilities	7.16	11.21	8	19.78	27.93	14.93
Long-Term Leases	0.05	0.01	0.05	0.07	0.1	0.08
Long-Term Unearned Revenue	-	36.78	21.81	1.17	5.9	0.02
Other Long-Term Liabilities	52.86	1.05	-0	-	-	-
Total Liabilities	61.11	49.05	29.85	21.01	33.94	15.03

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Common Stock	46.78	46.78	46.6	46.6	46.58	34.18
Additional Paid-In Capital	304.99	304.99	304.78	304.78	304.74	238.05
Retained Earnings	-376.82	-373.4	-331.12	-311.74	-291.39	-271.69
Comprehensive Income & Other	10.83	10.72	10.6	9.7	6.71	6.16
Shareholders' Equity	-14.22	-10.92	30.87	49.34	66.64	6.7
Total Liabilities & Equity	46.9	38.14	60.72	70.35	100.58	21.73

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 31, 2026	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Total Debt	0.05	0.11	0.16	5.83	15.98	10.63
Net Cash (Debt)	24.88	14.86	29.26	37.61	65.35	-4.49
Net Cash Growth	-24.89%	-49.20%	-22.20%	-42.45%	-	-
Net Cash Per Share	0.53	0.32	0.63	0.81	1.76	-0.14
Filing Date Shares Outstanding	46.78	46.78	46.6	46.6	46.58	34.18
Total Common Shares Outstanding	46.78	46.78	46.6	46.6	46.58	34.18
Working Capital	30.68	17.12	39.57	36.86	59.95	-5.92
Book Value Per Share	-0.30	-0.23	0.66	1.06	1.43	0.20
Tangible Book Value	-23.02	-19.75	22.01	40.44	57.7	-2.31
Tangible Book Value Per Share	-0.49	-0.42	0.47	0.87	1.24	-0.07
Buildings	-	6.44	8.37	8.1	-	-
Machinery	-	2.42	2.33	2.23	9.5	8.91

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error